Medite Cancer Diagnostics, Inc.·4

Nov 16, 12:31 PM ET

Weisman Susan 4

4 · Medite Cancer Diagnostics, Inc. · Filed Nov 16, 2017

Insider Transaction Report

Form 4
Period: 2017-04-26
Weisman Susan
CHIEF FINANCIAL OFFICER
Transactions
  • Award

    Common Stock

    2017-04-26$0.81/sh+200,000$162,000200,000 total

Documents

1 file
  • 4
    form4-11162017_091105.xmlPrimary